alexa Budget Implications For The UK NHS Of Implementing Mechanical Thrombectomy For The Treatment Of Acute Ischemic Stroke Patients: Calculation With The SolitaireTM Revascularization Device
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

11th World Congress on Neurology and Therapeutics
March 27-29, 2017 Madrid, Spain

Pablo Guijarro, Kyriakos Lobotesis, Roland Veltkamp, Isobel Carpenter and Lindsay M Claxton
Medtronic Ibérica, Spain
Imperial College Healthcare NHS Trust, UK
Division of Brain Sciences, Imperial College, UK
University of York, UK
Posters & Accepted Abstracts: J Neurol Neurophysiol
DOI: 10.4172/2155-9562.C1.047
Abstract
Objective: The aim of this study was to evaluate the cost savings of thrombectomy with a stent retriever (SolitaireTM Revascularization Device) in treating acute ischemic stroke patients from the UK healthcare provider perspective. Methods: Results from the SWIFT PRIME study were used to develop a Markov model estimating lifetime costs and effects of the addition of stent-retriever thrombectomy to tissue-type plasminogen activator (IV t-PA) treatment. Clinical effectiveness (measured by modified Rankin Scale score) and safety data were taken from the trial. Resource use was obtained from published data. Total costs were divided into acute, long-term and other costs (such as treatment, adverse event and recurrent stroke costs). Results: SolitaireTM + IV-tPA offer significant cost savings by helping more patients achieve functional independence (mRS 0-2). The higher treatment costs were offset by long-term cost savings. Solitaire™ intervention costs are negligible relative to the costs of managing functionally dependent patients at the hospital setting and lower than the cost of longer hospital lengths of stay for patients with functional dependence (mRS 3+). On an average one patient would save the NHS £47,000 over 5 years which represents potential savings of millions on an annual basis. Conclusions: Stent-retriever thrombectomy as an adjunct therapy to IV t-PA for acute ischemic stroke patients with large vessel occlusion is cost-saving option compared to IV-tPA alone.
Biography

Pablo Guijarro completed his BSc in Pharmacy from Complutense University, Spain and MSc in Health Economics from University of York, UK. He is Manager of Healthcare Economics, Policy & Reimbursement at Medtronic Neurovascular for the EMEA region. He has published papers in reputed international journals and has been invited as Lecturer at many congresses.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords